OTLK - DEADLINE ALERT: Bernstein Liebhard LLP Reminds Outlook Therapeutics Inc. Investors of Upcoming Deadline | Benzinga
NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
- Do you, or did you, own shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK)?
- Did you purchase your shares between December 29, 2022 and August 29, 2023, inclusive?
- Did you lose money in your investment in Outlook Therapeutics, Inc.?
- Do you want to discuss your rights?
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of Outlook Therapeutics, Inc. ("Outlook" or the "Company") (NASDAQ:OTLK) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
If you purchased or acquired Outlook securities, and/or would like to discuss your legal rights and options please visit Outlook Therapeutics, Inc. ...